Understanding The Impact Of Age And Chronic Infection On The T Cell Recognition And Control Of Infectious Disease
Funder
National Health and Medical Research Council
Funding Amount
$506,151.00
Summary
The effectiveness of immune responses to infectious diseases and vaccines declines during prolonged infection and is compromised in the very young and elderly. This research aims to better understand the compromise of the immune recognition and control of chronic infections and age-related defects in immunity. Such understanding is crucial to the development of strategies to improve the outcome of infections across the lifespan and the design of vaccines for chronic infections such as HIV.
Decoding The Transcriptional Program Of Vessel Growth In Health And Disease
Funder
National Health and Medical Research Council
Funding Amount
$463,652.00
Summary
Lymphatic vessels are essential to maintain fluid balance in most tissues of the human body. Further the lymphatic vasculature plays a central role during cancer and contributes to tumour metastasis. Despite this integral function in health and disease little is known about the molecular programs that coordinate gene expression to build a functional vasculature. This research project will address this gap in our knowledge and will open up new therapeutic avenues for lymphatic vascular disorders
Genomic Investigation Of Major Human Diseases And Lifespan
Funder
National Health and Medical Research Council
Funding Amount
$463,652.00
Summary
I am focused on finding disease genes for major human neurological diseases that increase with age. In my future research I will use human population genetics data combined with animal research to find genes that can block pain perception, or promote long life while preserving brain function in the elderly. My research efforts can help provide a better basic understanding of age-related diseases, and may help us identify new therapies to help us live productive, long lives.
The Signals Of Nerve Cells That Provide The Capacity For Sight
Funder
National Health and Medical Research Council
Funding Amount
$385,115.00
Summary
Sight relies on the signals of nerve cells in the brain, but we know little about the way in which nerve cells support this, or why in some people sight is diminished. In this work we will measure the signals of nerve cells in the visual pathway to gain knowledge of these processes: we will make measurements in normal animals and in those that suffer from brain disorders. Our work will provide a scientific basis for the diagnosis and treatment of these disorders.
Generation Of Mouse Models To Study The Roles Of Different Bcl-2 Family Members In The Regulation Of Apaptosis
Funder
National Health and Medical Research Council
Funding Amount
$420,872.00
Summary
Programmed cell death, or apoptosis, is required for the removal of infected, damaged or unwanted cells and its disrupted regulation is implicated in cancer, autoimmunity and degenerative disorders. The Bcl-2 family of proteins are key regulators of apoptosis. We propose to generate several mouse models to better understand the relationships between the different members of the Bcl-2 family in an effort to control this pathway for therapeutic purposes.
Autocrine Vitamin D Metabolism, Activity And Bone Health
Funder
National Health and Medical Research Council
Funding Amount
$459,270.00
Summary
This project will provide the detailed understanding of the activities of vitamin D within the bone microenvironment and offers the exciting prospect of elucidating the mechanistic reasons for maintaining an adequate vitamin D status in relation to the prevention of osteoporotic hip fractures. Thus, this project has great potential to improve community health by being able to recommend vitamin D supplementation made on the basis of maintaining normal bone cell function.
Neurodegenerative Disease Pathology, Mechanisms, Models And Treatments
Funder
National Health and Medical Research Council
Funding Amount
$431,000.00
Summary
Frontotemporal dementia (FTD) and motor neuron disease (MND) are fatal and incurable neurodegenerative diseases. Although dissimilar in symptoms, most cases of both FTD and MND are characterised at autopsy by abnormal accumulations of the TDP-43 protein in neurons. In this fellowship, I will characterise the biochemical changes caused by TDP-43 malfunction that occur in both FTD and MND and test potential new therapeutics in mice, to identify new ways to treat these devastating diseases.
Understanding The Mechanisms Of Action Of The ISCOMATRIX Adjuvant For The Development Of Human Vaccines
Funder
National Health and Medical Research Council
Funding Amount
$401,361.00
Summary
CSL Limited, an Australian owned global biopharmaceutical company, is developing the ISCOMATRIX (IMX) adjuvant for vaccines to prevent and treat serious human disease of global concern (e.g. cancer, pandemic flu, HPV, HCV). This study will identify the mechanisms of action of IMX in generating strong cellular immunity, how to enhance it further by combining with other immuno-modulators so as to develop novel IMX vaccines for the treatment of established cancer and persistent viral infections.
Wounds, burns and scalds are frequent injuries which can lead to deformity, disfigurement and loss of movement. We have shown that the cytoskeletal protein, Flightless I (FliI), is an important regulator of wound repair. We plan to further investigate FliI in wound and burn injuries using new cell-specific transgenic animal models and to develop a new FliI-antibody based therapy to treat wound and burn injuries.
Long-term Outcomes After Paediatric Traumatic Brain Injury
Funder
National Health and Medical Research Council
Funding Amount
$431,000.00
Summary
Traumatic brain injuries during early childhood often result in long-lasting issues including social behaviour problems and post-traumatic epilepsy. Using a unique model of brain injury in young mice, my research aims to identify the biology underlying the changes that cause these issues, and evaluate novel approaches to improve long-term outcomes after brain injury.